Skip to content

Public FDA record

Z-2223-2019: The Visibly Online Refractive Vision Test which is part of the Visibly Vision Test Solution, This is a so

Recall record Z-2223-2019 for Opternative Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2223-2019
Company in FDA record
Opternative Inc
FDA record creation date
Aug 8, 2019
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Lack of 510K clearance

Source facts

Action
The Visibly Online Refractive Vision Test is being recalled since the firm has not received authorization from FDA to market the product.
Initiated
2019-05-20
Root cause
No Marketing Application
Distribution
Worldwide distribution. US Nationwide distribution in the states of AZ, CA, DE, FL, IL, MO, NV, NY, OH, PA, TX, WA, and UT. Country of Canada.
Recall number
Z-2223-2019
Recall status
Open, Classified
CDRH record ID
174633
FDA record created
2019-08-08
Recall event number
83298

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗